Genome sequences of the 15 bluetongue virus vaccine strains incorporated in the South African live-attenuated vaccine
| dc.contributor.author | Mlingo, Tendai A.M. | |
| dc.contributor.author | Beeton-Kempen, Natasha | |
| dc.contributor.author | Nthangeni, M. Bethuel | |
| dc.contributor.author | Theron, Jacques | |
| dc.contributor.author | Mokoena, Nobalanda B. | |
| dc.date.accessioned | 2025-02-12T13:05:57Z | |
| dc.date.available | 2025-02-12T13:05:57Z | |
| dc.date.issued | 2024-06 | |
| dc.description | DATA AVAILABILITY : The raw sequence data as well as assembled sequence data of the 15 serotypes were deposited in GenBank under BioProject number PRJNA718723. The accession numbers are summarised in Table 1. Detailed information on the sequencing data generated for each serotype such as nucleotide identity and the South African reference strain applied is available in Table S1 in figshare (https://doi.org/10.6084/m9.figshare.25611486 25611486). | en_US |
| dc.description.abstract | Bluetongue disease in endemic areas is predominantly controlled through vaccination with live-attenuated vaccines. Sequencing of the original master seed viruses used in the production of Onderstepoort Biological Products vaccine was conducted. Nucleotide identities of 82.97%–100% were obtained for all sequences when compared to South African reference strains. | en_US |
| dc.description.department | Biochemistry, Genetics and Microbiology (BGM) | en_US |
| dc.description.librarian | am2024 | en_US |
| dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
| dc.description.sponsorship | Onderstepoort Biological Products, the University of Pretoria (Faculty of Natural and Agricultural Sciences), and the Chemical Industries Education and Training Authority. | en_US |
| dc.description.uri | https://journals.asm.org/journal/mra | en_US |
| dc.identifier.citation | Mlingo, T.A.M., Beeton-Kempen, N., Nthangeni, M.B. et al. 2024, 'Genome sequences of the 15 bluetongue virus vaccine strains incorporated in the South African live-attenuated vaccine', Microbiology Resource Announcements, vol. 13, no. 6, pp. 1-4. DOI: 10.1128/mra.00223-24. | en_US |
| dc.identifier.issn | 2576-098X | |
| dc.identifier.other | 10.1128/mra.00223-24 | |
| dc.identifier.uri | http://hdl.handle.net/2263/100789 | |
| dc.language.iso | en | en_US |
| dc.publisher | American Society for Microbiology | en_US |
| dc.rights | © 2024 Mlingo et al. This is an openaccess article distributed under the terms of the Creative Commons Attribution 4.0 International license. | en_US |
| dc.subject | Vaccines | en_US |
| dc.subject | Live-attenuated | en_US |
| dc.subject | Bluetongue virus | en_US |
| dc.subject | Bluetongue virus (BTV) | en_US |
| dc.subject | SDG-03: Good health and well-being | en_US |
| dc.title | Genome sequences of the 15 bluetongue virus vaccine strains incorporated in the South African live-attenuated vaccine | en_US |
| dc.type | Article | en_US |